Vault-13

FCPM III SERVICES B.V.

NAARDEN, P7 · CIK 2013410 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$369.2m reported value -10.8% vs Q1 2025
8positions
100.0%in top 10
1 new 1 added 1 reduced 0 sold out vs Q1 2025

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 10,632,113 $192.5m52.16% 52.16% ReducedShares held: Q3 2024 11.8m, Q4 2024 10.6m, Q1 2025 10.9m, Q2 2025 10.6m -303.2k -303,197 -2.8%
2 DYNE THERAPEUTICS INC COM DYN DYN 5,462,846 $52.0m14.09% 14.09% UnchangedShares held: Q3 2024 6.0m, Q4 2024 5.5m, Q1 2025 5.5m, Q2 2025 5.5m
3 REPLIMUNE GROUP INC COM REPL REPL 3,909,696 $36.3m9.84% 9.84% UnchangedShares held: Q3 2024 4.9m, Q4 2024 4.0m, Q1 2025 3.9m, Q2 2025 3.9m
4 ENGENE HOLDINGS INC COM COM 9,632,561 $35.1m9.50% 9.50% UnchangedShares held: Q3 2024 8.7m, Q4 2024 9.6m, Q1 2025 9.6m, Q2 2025 9.6m
5 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 3,452,330 $24.0m6.50% 6.50% UnchangedShares held: Q3 2024 2.3m, Q4 2024 3.5m, Q1 2025 3.5m, Q2 2025 3.5m
6 ASTRIA THERAPEUTICS INC COM CATB CATB 4,107,537 $23.4m6.34% 6.34% AddedShares held: Q3 2024 0, Q4 2024 2.9m, Q1 2025 3.8m, Q2 2025 4.1m +285.0k +285,000 7.5%
7 RAPT THERAPEUTICS INC COM NEW RAPT RAPT 440,176 $3.5m0.93% 0.93% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 440.2k
8 ENGENE HOLDINGS INC *W EXP 10/31/202 *W EXP 10/31/202 2,878,148 $2.4m0.64% 0.64% UnchangedShares held: Q3 2024 2.9m, Q4 2024 2.9m, Q1 2025 2.9m, Q2 2025 2.9m